Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 1
1966 1
1969 1
1970 1
1973 1
1978 1
1981 1
1983 3
1985 1
1986 2
1987 1
1989 1
1990 4
1991 2
1992 4
1994 2
1995 1
1997 1
1998 1
2000 4
2001 5
2002 15
2003 4
2004 9
2005 1
2006 1
2007 1
2008 1
2009 1
2015 1
2016 1
2018 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Demetri GD, et al. Among authors: capdeville r. N Engl J Med. 2002 Aug 15;347(7):472-80. doi: 10.1056/NEJMoa020461. N Engl J Med. 2002. PMID: 12181401 Free article. Clinical Trial.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators. O'Brien SG, et al. Among authors: capdeville r. N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457. N Engl J Med. 2003. PMID: 12637609 Free article. Clinical Trial.
Chronic myelogenous leukemia.
Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM. Druker BJ, et al. Among authors: capdeville r. Hematology Am Soc Hematol Educ Program. 2001:87-112. doi: 10.1182/asheducation-2001.1.87. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722980 Review.
Imatinib: the first 3 years.
Capdeville R, Silberman S, Dimitrijevic S. Capdeville R, et al. Eur J Cancer. 2002 Sep;38 Suppl 5:S77-82. doi: 10.1016/s0959-8049(02)80607-4. Eur J Cancer. 2002. PMID: 12528777 Review.
Implementation of mechanism of action biology-driven early drug development for children with cancer.
Pearson AD, Herold R, Rousseau R, Copland C, Bradley-Garelik B, Binner D, Capdeville R, Caron H, Carleer J, Chesler L, Geoerger B, Kearns P, Marshall LV, Pfister SM, Schleiermacher G, Skolnik J, Spadoni C, Sterba J, van den Berg H, Uttenreuther-Fischer M, Witt O, Norga K, Vassal G; Members of Working Group 1 of the Paediatric Platform of ACCELERATE. Pearson AD, et al. Among authors: capdeville r. Eur J Cancer. 2016 Jul;62:124-31. doi: 10.1016/j.ejca.2016.04.001. Epub 2016 May 31. Eur J Cancer. 2016. PMID: 27258969 Review.
Imatinib: a targeted clinical drug development.
Capdeville R, Silberman S. Capdeville R, et al. Semin Hematol. 2003 Apr;40(2 Suppl 2):15-20. doi: 10.1053/shem.2003.50037. Semin Hematol. 2003. PMID: 12783370 Review.
Colonic perforation during percutaneous nephrolithotomy.
Vallancien G, Capdeville R, Veillon B, Charton M, Brisset JM. Vallancien G, et al. Among authors: capdeville r. J Urol. 1985 Dec;134(6):1185-7. doi: 10.1016/s0022-5347(17)47680-4. J Urol. 1985. PMID: 4057413
78 results